Understanding Prudential Public Stocks – Analyzing the Fundamentals

By Blake Campbell • Wednesday, July 09 09:58 • Permanent Link

Large-cap Finance company Prudential Public has moved -1.3% so far today on a volume of 128,562, compared to its average of 955,765. In contrast, the S&P 500 index moved 1.0%.

Prudential Public trades -26.42% away from its average analyst target price of $33.71 per share. The 3 analysts following the stock have set target prices ranging from $31.23 to $36.91, and on average have given Prudential Public a rating of buy.

If you are considering an investment in PUK, you'll want to know the following:

Prudential Public's current price is 115.3% above its Graham number of $11.52, which implies that at its current valuation it does not offer a margin of safety
Prudential Public has moved 31.3% over the last year, and the S&P 500 logged a change of 10.5%
Based on its trailing earnings per share of 1.68, Prudential Public has a trailing 12 month Price to Earnings (P/E) ratio of 14.8 while the S&P 500 average is 29.3
PUK has a forward P/E ratio of 16.5 based on its forward 12 month price to earnings (EPS) of $1.5 per share
Its Price to Book (P/B) ratio is 3.75 compared to its sector average of 1.78
Prudential plc, through its subsidiaries, provides life and health insurance, and asset management solutions to individuals in Asia and Africa.
Based in Central, the company has 15,412 full time employees and a market cap of $31.86 Billion. Prudential Public currently returns an annual dividend yield of 0.9%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.